We're on-site at #PEGSEurope today ready to answer your questions about function-focused #SingleCellAnalysis. Join Paul Wylie's presentation TODAY at 12.15 pm GMT (Auditorium 3-4) and then meet the rest of the team at Booth #325 to see our Envisia technology in action!

We're looking forward to bringing our Envisia benchtop #SingleCellAnalysis platform to Lisbon for #PEGSEurope next week! Drop by poster session A078 on Nov. 11-12, or join a software demo at Booth #325. #microfluidics #ScienceSky 🧪 #AcademicSky

Just a couple of weeks until we're back at #PEGSEurope in Lisbon! Find the Lightcast team & our Envisia instrument at Stand #325, or join our luncheon presentation "Envisia: Advancing Antibody Discovery with Single-Cell, Function-Focused Profiling" on Nov. 11 at 12:15 PM. #SingleCell #Microfluidics

Day 2 of #ELRIGDD25 is just getting started! The Lightcast team is on-booth at #F08, ready to show you our Envisia benchtop platform and answer your questions about function-focused #SingleCell analysis!

We're looking forward to connecting at ELRIG #DrugDiscovery2025 next week! In this clip from last year's conference, Lightcast Dir. of Portfolio Management shares what he values most about being part of the ELRIG community. Find Paul and the Lightcast team in Booth F08!

“Phenotype tells you what a cell is — but 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 tells you if it has 𝗿𝗲𝗮𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹.” 💡 In this video, Lightcast Assoc. Dir. of Commercial Development Carrie Maynard explains why functional assays are so important for driving innovation in #DrugDiscovery. #ScienceSky #SingleCell

Antibody-based immunotherapies can target disease with high precision — but #AntibodyDiscovery workflows are slow & costly. Using streamlined functional analysis earlier in the discovery process can help deliver promising therapies quicker, writes our own Jonathan Didier. go.lightcast.bio/47R6ZoF

Why antibody discovery needs to focus on function

Early functional testing could transform the future of antibody-based therapies — here’s how.

drugdiscoverynews.com

#AntibodyDiscovery is at a turning point: traditional methods focused on binding rather than function are no longer sufficient. By leveraging droplet #microfluidics our Envisia platform enables deeper analysis of cellular functions. Learn more at our presentation @ the #FestivalofBiologics!

Our Envisia benchtop platform supports a wide range of #SingleCell functional assays — all designed to deepen understanding of cellular heterogeneity & cell-specific behaviours. Find out how you can quickly & more confidently identify promising candidates: go.lightcast.bio/42a4Dxc #Microfluidics

There's a hint of autumn in the air 🍂 , which can only mean one thing: Our team will soon be on the road again! Meet us at an upcoming event to find out more about unlocking deeper #SingleCell insights w/our Envisia benchtop platform. More info on our website: go.lightcast.bio/4n2itKm

Capturing functional readouts like 𝗯𝗶𝗼𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲 𝘀𝗲𝗰𝗿𝗲𝘁𝗶𝗼𝗻, 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗯𝗹𝗼𝗰𝗸𝗶𝗻𝗴 & 𝘁𝗮𝗿𝗴𝗲𝘁 𝗰𝗲𝗹𝗹 𝗸𝗶𝗹𝗹𝗶𝗻𝗴 at the #SingleCell level helps researchers gain a deeper understanding of cell behaviour & therapeutic potential, improving #DrugDiscovery timelines. Learn more: go.lightcast.bio/45WSPAP #ScienceSky 🧪

Our Envisia platform takes a function-focused approach to #AntibodyDiscovery, streamlining the discovery workflow with: 1️⃣ Real-time functional insights 2️⃣ Multi-assay screening 3️⃣ Faster hit identification & single-cell recovery 4️⃣ oEWOD technology to eliminate crosstalk go.lightcast.bio/47w2EH3

Four ways Envisia is changing the game in antibody discovery

By integrating single-cell analysis, multi-functional assays, and robust cell recovery into one seamless system, Lightcast empowers researchers to shift from a binding-first approach to a function-focused paradigm. Workflows on the Envisia platform has the potential to enhance lead quality, reduce attrition rates, and accelerate the discovery of antibodies with real therapeutic potential.

go.lightcast.bio

Whether we’re developing new workflows, implementing updates to our smart cartridge system, or testing new software features, one thing is clear: success comes from sharing & building on ideas within and across teams. Learn more about what drives our team: lnkd.in/e7gbeBeN #ScienceJobs #ScienceSky

Designed with scientists in mind, our software combines an intuitive user experience with powerful algorithms, enabling analysis of even the most complex functional behaviours. Get results faster, with less time spent learning a new software platform. (1/3) #ScienceSky #AcademicSky #SingleCell

Signal crosstalk between neighbouring cells or reactions can lead to noisy, unreliable data and compromised decision-making. The Envisia platform uses enclosed droplet microenvironments to isolate each cell and its functional assay. (1/3) #SingleCell #ScienceSky #Microfluidics

We're still seeking two commercial development associates to support the commercial expansion of our Envisia benchtop platform in the U.S. and European markets. Learn more and apply: go.lightcast.bio/4lHCKEp #ScienceJobs #ScienceSky 🧪 #Hiring

We're seeking a Commercial Development Associate to help us put our groundbreaking function-focused single-cell analysis technology into the hands of researchers in North America. 📍Boston, US Learn more & apply: go.lightcast.bio/3HTdg8q #ScienceSky #Hiring #ScienceJobs #ResearchJobs #AcademicSky

(1/3) Why does our Envisia platform use droplets? Picolitre-sized droplets are fundamental to isolating individual cells and enabling complex, multi-step assays — without losing biological context or introducing noise from secreted biomolecules. Learn more: go.lightcast.bio/3FZ0zby #microfluidics

Still relying on binding-focused approaches in #AntibodyDiscovery? You could be missing your best functional candidates. Envisia, our next-generation, single-cell platform, was designed to prioritise cellular & antibody functionality from the very start. go.lightcast.bio/4k0KyQa #ScienceSky 🧪

Four ways Envisia is changing the game in antibody discovery

By integrating single-cell analysis, multi-functional assays, and robust cell recovery into one seamless system, Lightcast empowers researchers to shift from a binding-first approach to a function-foc...

lightcast.bio

How can our benchtop Envisia platform accelerate #AntibodyDiscovery by bringing key cellular functions — including cytokine secretion, internalisation, and serial killing — into focus? Watch the video to learn more. #ScienceSky 🧪 #AcademicSky #Microfluidics www.youtube.com/watch?v=YctY...

Lightcast: The functional readouts guiding antibody discovery

YouTube video by Lightcast

youtube.com

From load to dispense in under 6 hours? Paul Wylie, Lightcast Dir. of Portfolio Management, walks through some of the Envisia #microfluidic platform's key features (like speed!), live from our booth at #PEGS2025. Learn more about Envisia: go.lightcast.bio/42ZdDGx www.youtube.com/watch?v=GjEW...

Lightcast at PEGS 2025

YouTube video by Lightcast

youtube.com

Last week at #PEGSummit, we were delighted to reveal our Envisia platform to a global audience — and even more thrilled by the interest and engagement we received. Watch the video to see Envisia in action & hear about Lightcast's plans for the future of #SingleCell. www.youtube.com/watch?v=pePx...

Showcasing the future of single-cell analysis at PEGS 2025

YouTube video by Lightcast

youtube.com

Centrally located among biotechs and universities in Kendall Square, our Boston Innovation Center (BIC) manages feasibility studies for our North American customers. 📹 Meet BIC Head Megan Gottlieb and Product Applications Scientist Jassmine Ibea. #ScienceSky 🧪 www.youtube.com/watch?v=57JW...

Meet the team at Lightcast's Boston Innovation Center

YouTube video by Lightcast

youtube.com

More about our Envisia benchtop platform: www.lightcast.bio/technology/e... #microfluidics #ScienceSky

#AntibodyDiscovery is often a slow process — especially when multiple functional assays are spread across different instruments in the lab. 👉 Discover how a unified, function-focused platform like Envisia accelerates the discovery process: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AcademicSky

With the Envisia platform, you can move beyond binding to perform key biochemical and cellular assays like antibody blocking, internalisation, and cytotoxicity — all before a candidate ever leaves the platform. Read our latest white paper: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AntibodyDiscovery

#JobAlert! Lightcast is hiring Commercial Development Associates in #Boston and #Cambridge (UK). Our ideal candidate has an MSc or PhD in #Biology, #Immunology, or a related field & some experience in the commercial side of biotech. Learn more and apply: www.lightcast.bio/careers #ScienceSky 🧪

Want to join our talented team? Check out open positions on our Careers page: www.lightcast.bio/careers

Recently, a few colleagues shared their artwork inspired by our home city of #Cambridge, featuring quiet moments along the River Cam, the charm of the Waterman pub, and the wisteria-covered buildings that brighten up any walk about town! Thanks to Alfonso, Anna and Greta for sharing their talents!

#JobAlert! Lightcast is hiring Commercial Development Associates in #Boston and #Cambridge (UK). Our ideal candidate has an MSc or PhD in #Biology, #Immunology, or a related field & some experience in the commercial side of biotech. Learn more and apply: www.lightcast.bio/careers #ScienceSky 🧪